Publications

Titlesort descending Year
The closed conformation of the LDL receptor is destabilized by the low Ca++ concentration but favored by the high Mg++ concentration in the endosome. 2016
X-ray Structures decipher the Non-equivalence of Serine and Threonine O-glycosylation points: Implications for the Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody. 2015
­A proactive role of water molecules in acceptor recognition by Protein-O-fucosyltransferase 2. 2016
A Bump-and-Hole Approach to Dissect Regulation of Protein O-Glycosylation. 2020
A hydrogen bond network in the active site of Anabaena Ferredoxin-NADP+ reductase modulates its catalytic efficiency. 2014
A mechanism-inspired UDP-N-acetylglucosamine pyrophosphorylase inhibitor 2020
A perspective on structural and mechanistic aspects of protein O-fucosylation. 2018
A trapped covalent intermediate of a glycoside hydrolase on the pathway to transglycosylation. Insights from experiments and QM/MM simulations. 2016
Anti-tumoral potential of a human granulysin-based, CEA-targeted cytolytic immunotoxin 2019
Asymmetric Synthesis of N-(Alkoxycarbonylmethyl)-3-Hydroxypyrrolidin-2-ones. 2013
Characterization and regulation of Leishmania major 3-hydroxy-3-methylglutaryl-CoA reductase. 2000
Characterization of the cDNA and in vitro expression of the ram seminal plasma protein RSVP 14 2013
Choline kinase active site provides features for designing versatile inhibitors. 2014
Choline Kinase Inhibition and Docking Studies of a Series of 6-(benzylthio)-9H-purin-9-yl-pyridinium derivatives. 2017
Cofactor processing galactose oxidase 2004
Cofactor processing in galactose oxidase. 2003
Combined structural snapshots and metadynamics reveal a substrate-guided front-face reaction for polypeptide GalNAc-transferase T2 . 2014
Cross-link formation of the cysteine 228-tyrosine 272 catalytic cofactor of galactose oxidase does not require dioxygen. 2008
Custom-site Modification of Cell Surface Fucosylation via Next Generation Fucosyltransferase Inhibitors. 2021
Design of alpha-S-neoglycopeptides derived from MUC1 with a flexible and solvent exposed sugar moiety. 2016

Pages